Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Junjing GUO"'
Publikováno v:
Shiyou shiyan dizhi, Vol 43, Iss 3, Pp 532-539 (2021)
The efficiency of hydrocarbon expulsion acts as a key geological factor for the study of hydrocarbon expulsion of conventional oil and gas, also, it indicates the enrichment degree of unconventional oil and/or gas. Based on the method of recovering t
Externí odkaz:
https://doaj.org/article/05e0c061285e4abeba69619e10e2e051
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e52189 (2012)
Gene therapy is a critical tool for the treatment of monogenic retinal diseases. However, the limited vector capacity of the current benchmark delivery strategy, adeno-associated virus (AAV), makes development of larger capacity alternatives, such as
Externí odkaz:
https://doaj.org/article/13c01cb42dd044be8b53f4eefec399ce
Autor:
Zhi Xin Geng, Feng Gao, Junjing Guo, Bingzhou Guo, Chunyu Liu, Taiwei Dong, Min Li, Yang Bai, Peifeng Wei
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2022 (2022)
Evidence-Based Complementary and Alternative Medicine, Vol 2022 (2022)
Objective. By integrating meta-analysis and network pharmacology strategy, the clinical efficacy of Zhishe Tongluo capsule in the treatment of cerebral infarction was evaluated, and the intervention mechanism was preliminary explored. Methods. Throug
Autor:
Samy I. McFarlane, Louis Salciccioli, Felix Nwamaghinna, Justina Ray, Abdullah Mahmood, Muhammad Dogar, Junjing Guo
Publikováno v:
American journal of medical case reports
We present a case of simultaneous cardiotoxicity and stroke-like neurotoxicity in a patient treated with FOLFOX, a 5-Fluorouracil (5-FU)-containing chemotherapy regimen. Within hours of FOLFOX infusion, the patient began to exhibit signs and symptoms
Publikováno v:
Journal of pain and symptom management. 58(4)
Autor:
Rajendra Narayan Mitra, Muna I. Naash, Junjing Guo, Zongchao Han, Rasha Makkia, Chance A. Nichols, Mark J. Cooper
Publikováno v:
Journal of Controlled Release. 236:31-37
We recently reported that the Ins2(Akita) mouse is a good model for late-onset diabetic retinopathy. Here, we investigated the effect of miR200-b, a potential anti-angiogenic factor, on VEGF receptor 2 (VEGFR-2) expression and to determine the underl
Autor:
Junjing Guo, Emil Chynn
Publikováno v:
Advances in Ophthalmology & Visual System. 6
Publikováno v:
The Journal of Pathology. 219:446-454
Vascular endothelial growth factor (VEGF-A) is a major pathogenic factor and a therapeutic target for age-related macular degeneration, diabetic retinopathy, and retinopathy of prematurity. Despite intensive effort in the field, the cellular mechanis
Autor:
Shanshan, Hu, Junjing, Guo, Binbin, Wang, Jing, Wang, Zhou, Zhou, Guangkai, Zhou, Xuchen, Ding, Xu, Ma, Yanhua, Qi
Publikováno v:
Molecular Vision
Purpose The purpose of this study was to identify the mutation(s) or deletion(s) of the forkhead box protein L2 (FOXL2) gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Methods Genomic DNA extracted from peri
Autor:
Yanyan, Bai, Jian-xing, Ma, Junjing, Guo, Juanjuan, Wang, Meili, Zhu, Ying, Chen, Yun-Zheng, Le
Publikováno v:
The Journal of pathology. 219(4)
Vascular endothelial growth factor (VEGF-A) is a major pathogenic factor and a therapeutic target for age-related macular degeneration, diabetic retinopathy, and retinopathy of prematurity. Despite intensive effort in the field, the cellular mechanis